Page last updated: 2024-10-28

beta-thujaplicin and Atherogenesis

beta-thujaplicin has been researched along with Atherogenesis in 1 studies

beta-thujaplicin: structure
beta-thujaplicin : A monoterpenoid that is cyclohepta-2,4,6-trien-1-one substituted by a hydroxy group at position 2 and an isopropyl group at position 4. Isolated from Thuja plicata and Chamaecyparis obtusa, it exhibits antimicrobial activities.

Research Excerpts

ExcerptRelevanceReference
"The progression of atherosclerosis is linked to proliferation and migration of vascular smooth muscle cell via MMP-2 and MMP-9 activities."1.48Treatment of β-thujaplicin counteracts di(2-ethylhexyl)phthalate (DEHP)-exposed vascular smooth muscle activation, inflammation and atherosclerosis progression. ( Cherng, JY; Liu, CC; Pan, KH; Shen, CR; Shih, MF, 2018)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Shih, MF1
Pan, KH1
Liu, CC1
Shen, CR1
Cherng, JY1

Other Studies

1 other study available for beta-thujaplicin and Atherogenesis

ArticleYear
Treatment of β-thujaplicin counteracts di(2-ethylhexyl)phthalate (DEHP)-exposed vascular smooth muscle activation, inflammation and atherosclerosis progression.
    Regulatory toxicology and pharmacology : RTP, 2018, Volume: 92

    Topics: Animals; Atherosclerosis; Cell Line; Diethylhexyl Phthalate; Disease Progression; E-Selectin; Endoth

2018